Characteristics, correlates, and assessment of psychosis in Parkinson disease without dementia

Parkinsonism and Related Disorders

Volumn 43, Issue , 2017, Pages 56-60

  Barrett, Matthew J ^a   Smolkin, Mark E ^b   Flanigan, Joseph L ^a   Shah, Binit B ^a   Harrison, Madaline B ^a   Sperling, Scott A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Parkinson disease; Psychosis; Psychotic disorders; Visual hallucinations; Visual illusions

Indexed keywords

AMANTADINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PRAMIPEXOLE; QUETIAPINE; ROPINIROLE; ROTIGOTINE;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; BRAIN STEM INJURY; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE BURDEN; DISEASE SEVERITY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE ASSESSMENT; MIDDLE AGED; MONTREAL COGNITIVE ASSESSMENT; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PARASOMNIA; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; SCALE FOR THE ASSESSMENT OF POSITIVE SYMPTOMS; SENSITIVITY AND SPECIFICITY; SYMPTOM; TREATMENT DURATION; UNIFIED PARKINSON DISEASE RATING SCALE; VISUAL HALLUCINATION; VISUAL ILLUSION; COHORT ANALYSIS; COMPLICATION; DELUSION; HALLUCINATION; PSYCHOLOGICAL RATING SCALE; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DELUSIONS; FEMALE; HALLUCINATIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REM SLEEP BEHAVIOR DISORDER;

EID: 85025429306     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2017.07.011     Document Type: Article

References (31)

1. Hely, M.A., Reid, W.G., Adena, M.A., Halliday, G.M., Morris, J.G., The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov. Disord. 23 (2008), 837–844, 10.1002/mds.21956.
2. Pagonabarraga, J., Martinez-Horta, S., Fernandez de Bobadilla, R., Perez, J., Ribosa-Nogue, R., Marin, J., Pascual-Sedano, B., Garcia, C., Gironell, A., Kulisevsky, J., Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase. Mov. Disord. 31 (2016), 45–52, 10.1002/mds.26432.
3. Aarsland, D., Andersen, K., Larsen, J.P., Lolk, A., Kragh-Sorensen, P., Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch. Neurol. 60 (2003), 387–392.
4. Aarsland, D., Larsen, J.P., Tandberg, E., Laake, K., Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J. Am. Geriatr. Soc. 48 (2000), 938–942.
5. McKinlay, A., Grace, R.C., Dalrymple-Alford, J.C., Anderson, T., Fink, J., Roger, D., A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia. Park. Relat. Disord. 14 (2008), 37–42 S1353-8020(07)00095-8 [pii].
6. Goetz, C.G., Stebbins, G.T., Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology 45 (1995), 669–671.
7. Fenelon, G., Alves, G., Epidemiology of psychosis in Parkinson's disease. J. Neurol. Sci. 289 (2010), 12–17, 10.1016/j.jns.2009.08.014.
8. Williams, D.R., Lees, A.J., Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol. 4 (2005), 605–610 S1474-4422(05)70146-0 [pii].
9. Dalrymple-Alford, J.C., MacAskill, M.R., Nakas, C.T., Livingston, L., Graham, C., Crucian, G.P., Melzer, T.R., Kirwan, J., Keenan, R., Wells, S., Porter, R.J., Watts, R., Anderson, T.J., The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 75 (2010), 1717–1725, 10.1212/WNL.0b013e3181fc29c9.
10. Tomlinson, C.L., Stowe, R., Patel, S., Rick, C., Gray, R., Clarke, C.E., Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov. Disord. 25 (2010), 2649–2653, 10.1002/mds.23429.
11. Ravina, B., Marder, K., Fernandez, H.H., Friedman, J.H., McDonald, W., Murphy, D., Aarsland, D., Babcock, D., Cummings, J., Endicott, J., Factor, S., Galpern, W., Lees, A., Marsh, L., Stacy, M., Gwinn-Hardy, K., Voon, V., Goetz, C., Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov. Disord. 22 (2007), 1061–1068, 10.1002/mds.21382.
12. Starkstein, S.E., Mayberg, H.S., Preziosi, T.J., Andrezejewski, P., Leiguarda, R., Robinson, R.G., Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J. Neuropsychiatry Clin. Neurosci. 4 (1992), 134–139, 10.1176/jnp.4.2.134.
13. Stiasny-Kolster, K., Mayer, G., Schafer, S., Moller, J.C., Heinzel-Gutenbrunner, M., Oertel, W.H., The REM sleep behavior disorder screening questionnaire–a new diagnostic instrument. Mov. Disord. 22 (2007), 2386–2393, 10.1002/mds.21740.
14. Hogl, B., Arnulf, I., Comella, C., Ferreira, J., Iranzo, A., Tilley, B., Trenkwalder, C., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G.T., Schrag, A., Goetz, C.G., Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Mov. Disord. 25 (2010), 2704–2716, 10.1002/mds.23190.
15. Schrag, A., Barone, P., Brown, R.G., Leentjens, A.F., McDonald, W.M., Starkstein, S., Weintraub, D., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G.T., Goetz, C.G., Depression rating scales in Parkinson's disease: critique and recommendations. Mov. Disord. 22 (2007), 1077–1092, 10.1002/mds.21333.
16. Fenelon, G., Soulas, T., Zenasni, F., Cleret de Langavant, L., The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria. Mov. Disord. 25 (2010), 763–766, 10.1002/mds.22839.
17. Frei, K., Truong, D.D., Hallucinations and the spectrum of psychosis in Parkinson's disease. J. Neurol. Sci. 374 (2017), 56–62 S0022-510X(17)30013-8 [pii].
18. Harding, A.J., Broe, G.A., Halliday, G.M., Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 125 (2002), 391–403.
19. Gallagher, D.A., Parkkinen, L., O'Sullivan, S.S., Spratt, A., Shah, A., Davey, C.C., Bremner, F.D., Revesz, T., Williams, D.R., Lees, A.J., Schrag, A., Testing an aetiological model of visual hallucinations in Parkinson's disease. Brain 134 (2011), 3299–3309, 10.1093/brain/awr225.
20. Ffytche, D.H., Creese, B., Politis, M., Chaudhuri, K.R., Weintraub, D., Ballard, C., Aarsland, D., The psychosis spectrum in Parkinson disease. Nat. Rev. Neurol. 13 (2017), 81–95, 10.1038/nrneurol.2016.200.
21. Gjerstad, M.D., Boeve, B., Wentzel-Larsen, T., Aarsland, D., Larsen, J.P., Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson's disease over time. J. Neurol. Neurosurg. Psychiatry 79 (2008), 387–391 jnnp.2007.116830 [pii].
22. Pacchetti, C., Manni, R., Zangaglia, R., Mancini, F., Marchioni, E., Tassorelli, C., Terzaghi, M., Ossola, M., Martignoni, E., Moglia, A., Nappi, G., Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov. Disord. 20 (2005), 1439–1448, 10.1002/mds.20582.
23. Boeve, B.F., Silber, M.H., Saper, C.B., Ferman, T.J., Dickson, D.W., Parisi, J.E., Benarroch, E.E., Ahlskog, J.E., Smith, G.E., Caselli, R.C., Tippman-Peikert, M., Olson, E.J., Lin, S.C., Young, T., Wszolek, Z., Schenck, C.H., Mahowald, M.W., Castillo, P.R., Del Tredici, K., Braak, H., Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130 (2007), 2770–2788 awm056 [pii].
24. Jellinger, K.A., Neuropathobiology of non-motor symptoms in Parkinson disease. J. Neural Transm. (Vienna) 122 (2015), 1429–1440, 10.1007/s00702-015-1405-5.
25. Boeve, B.F., Silber, M.H., Ferman, T.J., Lin, S.C., Benarroch, E.E., Schmeichel, A.M., Ahlskog, J.E., Caselli, R.J., Jacobson, S., Sabbagh, M., Adler, C., Woodruff, B., Beach, T.G., Iranzo, A., Gelpi, E., Santamaria, J., Tolosa, E., Singer, C., Mash, D.C., Luca, C., Arnulf, I., Duyckaerts, C., Schenck, C.H., Mahowald, M.W., Dauvilliers, Y., Graff-Radford, N.R., Wszolek, Z.K., Parisi, J.E., Dugger, B., Murray, M.E., Dickson, D.W., Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep. Med. 14 (2013), 754–762, 10.1016/j.sleep.2012.10.015.
26. Geddes, M.R., Tie, Y., Gabrieli, J.D., McGinnis, S.M., Golby, A.J., Whitfield-Gabrieli, S., Altered functional connectivity in lesional peduncular hallucinosis with REM sleep behavior disorder. Cortex 74 (2016), 96–106, 10.1016/j.cortex.2015.10.015.
27. Aarsland, D., Larsen, J.P., Cummins, J.L., Laake, K., Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch. Neurol. 56 (1999), 595–601.
28. Forsaa, E.B., Larsen, J.P., Wentzel-Larsen, T., Goetz, C.G., Stebbins, G.T., Aarsland, D., Alves, G., A 12-year population-based study of psychosis in Parkinson disease. Arch. Neurol. 67 (2010), 996–1001, 10.1001/archneurol.2010.166.
29. Llebaria, G., Pagonabarraga, J., Martinez-Corral, M., Garcia-Sanchez, C., Pascual-Sedano, B., Gironell, A., Kulisevsky, J., Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease. Mov. Disord. 25 (2010), 2785–2791, 10.1002/mds.23411.
30. Stowe, R.L., Ives, N.J., Clarke, C., van Hilten, J., Ferreira, J., Hawker, R.J., Shah, L., Wheatley, K., Gray, R., Dopamine agonist therapy in early Parkinson's disease. Cochrane Database Syst. Rev.(2), 2008, CD006564, 10.1002/14651858.CD006564.pub2.
31. Morgante, L., Colosimo, C., Antonini, A., Marconi, R., Meco, G., Pederzoli, M., Pontieri, F.E., Cicarelli, G., Abbruzzese, G., Zappulla, S., Ramat, S., Manfredi, M., Bottacchi, E., Abrignani, M., Berardelli, A., Cozzolino, A., Paradiso, C., De Gaspari, D., Morgante, F., Barone, P., PRIAMO study group, psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression. J. Neurol. Neurosurg. Psychiatry 83 (2012), 76–82, 10.1136/jnnp-2011-300043.